Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPension (IS)Preferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bruker (BRKR) Research & Development (2016 - 2025)

Bruker (BRKR) has disclosed Research & Development for 16 consecutive years, with $99.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Research & Development fell 4.6% year-over-year to $99.6 million, compared with a TTM value of $395.2 million through Dec 2025, up 4.97%, and an annual FY2025 reading of $395.2 million, up 4.97% over the prior year.
  • Research & Development was $99.6 million for Q4 2025 at Bruker, up from $98.3 million in the prior quarter.
  • Across five years, Research & Development topped out at $104.4 million in Q4 2024 and bottomed at $52.1 million in Q3 2021.
  • Average Research & Development over 5 years is $76.2 million, with a median of $71.1 million recorded in 2023.
  • The sharpest move saw Research & Development skyrocketed 10320.0% in 2021, then dropped 4.6% in 2025.
  • Year by year, Research & Development stood at $58.1 million in 2021, then increased by 9.29% to $63.5 million in 2022, then skyrocketed by 31.5% to $83.5 million in 2023, then increased by 25.03% to $104.4 million in 2024, then decreased by 4.6% to $99.6 million in 2025.
  • Business Quant data shows Research & Development for BRKR at $99.6 million in Q4 2025, $98.3 million in Q3 2025, and $100.2 million in Q2 2025.